Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (5)
COVID-19 (14)
Type
Type
Guidance (660)
NICE advice (1)
Quality standard (25)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (5)
Clinical guidelines (45)
COVID-19 rapid guidelines (2)
Diagnostics guidance (23)
Diagnostics guidanceDiagnostics guidance (5)
Health technology evaluations (10)
Highly specialised technologies guidance (20)
Interventional procedures guidance (19)
Interventional procedures guidanceInterventional procedures guidance (20)
Medical technologies guidance (12)
Medical technologies guidanceMedical technologies guidance (9)
Medicines practice guidelines (1)
NICE guidelines (81)
Public health guidelines (3)
Social care guidelines (1)
Technology appraisal guidance (467)
Advice programme
Advice programme
Medtech innovation briefings (1)
Apply filters
Showing 1 to 10 of 686
Sort by
Title
Date
Apply sorting
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]
Technology appraisal guidance
TBC
Abemaciclib for treating KRAS mutation-positive non-small-cell lung cancer after platinum-based chemotherapy ID1147
Technology appraisal guidance
TBC
Abemaciclib monotherapy for treating advanced hormone-receptor positive, HER2-negative breast cancer after endocrine therapy and chemotherapy ID1347
Technology appraisal guidance
TBC
Abicipar pegol for treating wet age-related macular degeneration ID1533
Technology appraisal guidance
TBC
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]
Technology appraisal guidance
TBC
Acute kidney injury (update)
Quality standard
23 March 2023
ADI-PEG 20 for previously treated hepatocellular carcinoma [ID1025]
Technology appraisal guidance
TBC
Adrenal insufficiency: acute and long-term management
NICE guideline
11 April 2024
Aducanumab for treating mild cognitive impairment and mild dementia caused by Alzheimer's disease [ID3763]
Technology appraisal guidance
TBC
Advocacy services for adults with health and social care needs
NICE guideline
9 November 2022
Current page
1
2
3
…
69
Page
1
of
69
Next page
Results per page
10
25
50
All
Back to top